SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-22-006927
Filing Date
2022-01-24
Accepted
2022-01-24 16:36:43
Documents
2
Period of Report
2022-01-13

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm223246-7_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm223246-7_3seq1.xml 3 1920
2 EXHIBIT 24 tm223246d7_ex24.htm EX-24 7942
  Complete submission text file 0001104659-22-006927.txt   11339
Mailing Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116
Business Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116 857-327-7737
GELESIS HOLDINGS, INC. (Issuer) CIK: 0001805087 (see all company filings)

IRS No.: 844730610 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2407 S. CONGRESS AVE SUITE E103 AUSTIN TX 78704
Business Address
Christopher Clayton (Reporting) CIK: 0001851393 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39362 | Film No.: 22549838